This is a randomized, double-blind, placebo-controlled, multicenter, parallel-group study in adult and adolescent subjects with moderate-to-severe AD. Eligible subjects must have a documented history of inadequate response to topical AD …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 12 and above
TRIAL STATUS: Active, not recruiting
OVERVIEW The Holdsworth House Research team are currently seeking volunteers to trial a new possible Type 2 Diabetes therapy. We are seeking patients whose diabetes control could be improved. There …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Researchers at NICM Health Research Institute are seeking participants to join a clinical trial investigating the effectiveness and safety of an herbal medicine for the management of osteoarthritis of the …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 40 to 75 years
TRIAL STATUS: Closed: follow-up complete
Research Centre: NICM Health Research Institute, Western Sydney University Location: Online and via phone. No face to face contact is required with any member of the research team. Lead Doctor: …
CONDITION: Other
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Primary Objective: To determine the change in the following parameters following administration of RadianiX ™ Skin Melanin Index and Erythema Score Skin Hyperpigmentation Skin Elasticity Visual Skin Properties Skin Luminosity …
CONDITION: Skin
GENDER: Females
AGE GROUP: 30 to 65 years
TRIAL STATUS: Completed
CheckMate-901 is a phase 3 open-label clinical research study of drugs named nivolumab and ipilimumab. This study will test these drugs in adults with cancer of the bladder or upper …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Completed
This is an open-label Phase 1/2 study to assess the safety and tolerability of combination PD-1 inhibitor (nivolumab) administered concomitantly with c-Met inhibitor (APL-101), to determine the recommended Phase 2 …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Terminated
POLARIS is a Phase 2 research trial testing a potential new treatment for BRAFV600-mutant positive melanoma that has spread to the brain. The new treatment is called encorafenib (Braftovi) + …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Terminated
This is a Phase III, randomized, double-blind, placebo-controlled, multi-center, global study to assess the efficacy and safety of durvalumab in combination with bevacizumab or durvalumab monotherapy or placebo as adjuvant …
CONDITION: Cancer
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
An Australian researcher is testing an investigational cream for plaque psoriasis. Participants will receive investigational cream (active study drug) or placebo. Investigational medication and study-related care will be provided at …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 75 years
TRIAL STATUS: Recruiting
Depression affects millions. Millions of people worldwide have major depressive disorder, the most commonly diagnosed form of depression. Depression is more than just sadness. It interferes with daily life and …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 to 80 years
TRIAL STATUS: Recruiting
The StandingTall team, has worked with over 500 community-dwelling older people since 2015, implementing a home-based balance exercise program delivered through a tablet computer. By embracing technology, we are providing …
CONDITION: Injuries and Accidents
GENDER: Both males and females
AGE GROUP: 65 and above
TRIAL STATUS: Recruiting
Novatrials is seeking volunteers with moderate to severe Eczema (Atopic Dermatitis) to participate in a clinical trial under the supervision of Dermatologist Dr Lior Sagi, to test the safety and effectiveness …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 to 65 years
TRIAL STATUS: Recruiting
Youth aged 12 to 17 with a history of eczema (atopic dermatitis) for at least one year, may qualify to participate in this study. Adolescents must have moderate to severe …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 12 to 17 years
TRIAL STATUS: Active, not recruiting
Update February 2020: Recruitment for this study has now closed. Have you had one or more gout attacks in the past 12 months and do you have access to a …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Join a new research trial Are you suffering pain after Shingles? Have you had shingles on your body? Are you experiencing pain 3 months after an outbreak? If you have …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Join a diabetes trial Living with pain in your feet? Do you have diabetes? Have you had significant pain for at least 6 months or more? If you have answered …
CONDITION:
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Recruiting
Seeking healthy male participants who do not have any history of asthma or hayfever. The purpose of this study is to investigate a new asthma medication, though at this early …
CONDITION: Other
GENDER: Males
AGE GROUP: 18 to 55 years
TRIAL STATUS: Recruiting
The RESTORE clinical trial is a large scale research study in Australia exploring back pain treatments. We are trying to measure how effective existing treatments are for people with persistent …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
The RESTORE clinical trial is a large scale research study in Australia exploring back pain treatments. We are trying to measure how effective existing treatments are for people with persistent …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Closed: follow-up continuing
We have completed recruitment for the ‘RESOLVE trial for chronic low back pain’, a commonwealth government funded randomised controlled trial in which we are investigating the effectiveness of new treatment …
CONDITION: Musculoskeletal
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Closed: follow-up continuing
Alzheimer’s disease is a progressive disease that destroys memory along with other significant mental functions. While current treatment can help, there are no known cures. The research study involves testing …
CONDITION: Neurological
GENDER: Females
AGE GROUP: 50 to 80 years
TRIAL STATUS: Recruiting
Scientia Clinical trial is seeking participants to join a clinical trial. The clinical trial involves wearing a patch for one week. Participants will need to be available for 10 days …
CONDITION: Other
GENDER: Females
AGE GROUP: 25 to 50 years
TRIAL STATUS: Completed
We are testing a treatment developed for polycythemia vera, which is a condition that has limited therapeutic options and no cure is currently available. The medication will be administered subcutaneously …
CONDITION: Other
GENDER: Males
AGE GROUP: 18 to 50 years
TRIAL STATUS: Completed
Signs and symptoms of Alzheimer’s disease We all experience memory issues from time to time. But experiencing the following more and more often may be an early sign of Alzheimer’s …
CONDITION: Neurological
GENDER: Both males and females
AGE GROUP: 60 to 85 years
TRIAL STATUS: Recruiting
Background Depression is a serious and disabling illness that affects millions of people every year. Many of those struggling with depression feel that currently available antidepressants have not adequately treated …
CONDITION: Mental Health
GENDER: Both males and females
AGE GROUP: 18 to 70 years
TRIAL STATUS: Recruiting
Australian researchers are testing a new medication for idiopathic pulmonary fibrosis. This is a 60 day study with 10 separate visits. You will be treated at no cost, and most …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 40 to 80 years
TRIAL STATUS: Completed
Title: A non-interventional, prospective 12 months study to characterize the REAL-life effectiveness and treatment patterns of Secukinumab and current standard of care in patient with chronic plaque psoriAsis eligible for …
CONDITION: Skin
GENDER: Both males and females
AGE GROUP: 18 and above
TRIAL STATUS: Active, not recruiting
Australian researchers are testing a new oral medication for severe asthma. This is a 52 week study with 11 separate visits and 6 telephone calls. You will be treated at …
CONDITION: Respiratory
GENDER: Both males and females
AGE GROUP: 12 and above
TRIAL STATUS: Recruiting
Australian researchers are testing a potential new treatment for type 2 diabetes mellitus. They are looking for volunteers to participate in this study, which includes up to 4 separate clinic …
CONDITION: Metabolic and Endocrine
GENDER: Both males and females
AGE GROUP: 20 to 80 years
TRIAL STATUS: Closed: follow-up complete
